Table of Contents Author Guidelines Submit a Manuscript
Clinical and Developmental Immunology
Volume 2012, Article ID 239691, 7 pages
http://dx.doi.org/10.1155/2012/239691
Review Article

Dermatitis Herpetiformis: From the Genetics to the Development of Skin Lesions

1Section of Dermatology, Department of Medical and Surgical Clinical Care, University of Florence, 50129 Florence, Italy
2Department of Clinical Physiopathology, University of Florence, 50139 Florence, Italy

Received 13 February 2012; Accepted 11 April 2012

Academic Editor: Takashi Hashimoto

Copyright © 2012 Diletta Bonciani et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. Kárpáti, “Dermatitis herpetiformis,” Clinics in Dermatology, vol. 30, no. 1, pp. 56–59, 2012. View at Google Scholar
  2. D. Bolotin and V. Petronic-Rosic, “Dermatitis herpetiformis: part I. Epidemiology, pathogenesis, and clinical presentation,” Journal of the American Academy of Dermatology, vol. 64, no. 6, pp. 1017–1024, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. K. Kaukinen, P. Collin, and M. Mäki, “Latent coeliac disease or coeliac disease beyond villous atrophy?” Gut, vol. 56, no. 10, pp. 1339–1340, 2007. View at Publisher · View at Google Scholar · View at Scopus
  4. R. Troncone and B. Jabri, “Coeliac disease and gluten sensitivity,” Journal of Internal Medicine, vol. 269, no. 6, pp. 582–590, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. D. Bolotin and V. Petronic-Rosic, “Dermatitis herpetiformis: part II. Diagnosis, management, and prognosis,” Journal of the American Academy of Dermatology, vol. 64, no. 6, pp. 1027–1033, 2011. View at Publisher · View at Google Scholar · View at Scopus
  6. L. Fry, “Dermatitis herpetiformis: problems, progress and prospects,” European Journal of Dermatology, vol. 12, no. 6, pp. 523–531, 2002. View at Google Scholar · View at Scopus
  7. S. W. Yeh, B. Ahmed, N. Sami, and A. R. Ahmed, “Blistering disorders: diagnosis and treatment,” Dermatologic Therapy, vol. 16, no. 3, pp. 214–223, 2003. View at Publisher · View at Google Scholar · View at Scopus
  8. M. E. O. Nicolas, P. K. Krause, L. E. Gibson, and J. A. Murray, “Dermatitis herpetiformis,” International Journal of Dermatology, vol. 42, no. 8, pp. 588–600, 2003. View at Publisher · View at Google Scholar · View at Scopus
  9. P. Fabbri and M. Caproni, “Dermatitis herpetiformis,” Orphanet Encyclopedia, http://www.orpha.net/data/patho/GB/ uk-DermatitisHerpetiformis.pdf, 2005.
  10. M. Caproni, E. Antiga, L. Melani, and P. Fabbri, “Guidelines for the diagnosis and treatment of dermatitis herpetiformis,” Journal of the European Academy of Dermatology and Venereology, vol. 23, no. 6, pp. 633–638, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. C. J. Ko, O. R. Colegio, J. E. Moss, and J. M. McNiff, “Fibrillar IgA deposition in dermatitis herpetiformis—an underreported pattern with potential clinical significance,” Journal of Cutaneous Pathology, vol. 37, no. 4, pp. 475–477, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. M. Shibahara, H. Nanko, M. Shimizu et al., “Dermatitis herpetiformis in Japan: an update,” Dermatology, vol. 204, no. 1, pp. 37–42, 2002. View at Publisher · View at Google Scholar · View at Scopus
  13. S. Ingen-Housz-Oro, “Dermatitis herpetiformis: a review,” Annales de Dermatologie et de Venereologie, vol. 138, no. 3, pp. 221–227, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. M. Sárdy and J. Tietze, “Dermatitis herpetiformis:An update of the pathogenesis,” Hautarzt, vol. 60, no. 8, pp. 627–632, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. A. Spurkland, G. Ingvarsson, E. S. Falk, I. Knutsen, L. M. Sollid, and E. Thorsby, “Dermatitis herpetiformis and celiac disease are both primarily associated with the HLA-DQ (α1*0501, β1*02) or the HLA-DQ (α1*03, β1*0302) heterodimers,” Tissue Antigens, vol. 49, no. 1, pp. 29–34, 1997. View at Google Scholar · View at Scopus
  16. E. Marietta, K. Black, M. Camilleri et al., “A new model for dermatitis herpetiformis that uses HLA-DQ8 transgenic NOD mice,” Journal of Clinical Investigation, vol. 114, no. 8, pp. 1090–1097, 2004. View at Publisher · View at Google Scholar · View at Scopus
  17. J. A. Sachs, J. Awad, and D. McCloskey, “Different HLA associated gene combinations contribute to susceptibility for coeliac disease and dermatitis herpetiformis,” Gut, vol. 27, no. 5, pp. 515–520, 1986. View at Google Scholar · View at Scopus
  18. S. I. Katz, K. C. Hertz, G. N. Rogentine, and W. Strober, “HLA-B8 and dermatitis herpetiformis in patients with IgA deposits in skin,” Archives of Dermatology, vol. 113, no. 2, pp. 155–156, 1977. View at Publisher · View at Google Scholar · View at Scopus
  19. S. I. Katz, Z. M. Falchuk, M. V. Dahl, G. N. Rogentine, and W. Strober, “HL-A8: a genetic link between dermatitis herpetiformis and gluten-sensitive enteropathy,” Journal of Clinical Investigation, vol. 51, no. 11, pp. 2977–2980, 1972. View at Google Scholar · View at Scopus
  20. S. Karpati, I. Kosnai, and M. Verkasalo, “HLA antigens, jejunal morphology and associated diseases in children with dermatitis herpetiformis,” Acta Paediatrica Scandinavica, vol. 75, no. 2, pp. 297–301, 1986. View at Google Scholar · View at Scopus
  21. R. P. Hall III, M. E. Sanders, R. J. Duquesnoy, S. I. Katz, and S. Shaw, “Alterations in HLA-DP and HLA-DQ antigen frequency in patients with dermatitis herpetiformis,” Journal of Investigative Dermatology, vol. 93, no. 4, pp. 501–505, 1989. View at Google Scholar · View at Scopus
  22. K. Tokunaga and T. Juji, “Distribution of MHC alleles in Japanese,” Nippon Rinsho, vol. 48, pp. 489–493, 1990. View at Google Scholar
  23. K. Hervonen, K. Karell, P. Holopainen, P. Collin, J. Partanen, and T. Reunala, “Concordance of dermatitis herpetiformis and celiac disease in monozygous twins,” Journal of Investigative Dermatology, vol. 115, no. 6, pp. 990–993, 2000. View at Publisher · View at Google Scholar · View at Scopus
  24. K. Hervonen, M. Hakanen, K. Kaukinen, P. Collin, and T. Reunala, “First-degree relatives are frequently affected in coeliac disease and dermatitis herpetiformis,” Scandinavian Journal of Gastroenterology, vol. 37, no. 1, pp. 51–55, 2002. View at Publisher · View at Google Scholar · View at Scopus
  25. M. J. Van Belzen, J. W. R. Meijer, L. A. Sandkuijl et al., “A major non-HLA locus in celiac disease maps to chromosome 19,” Gastroenterology, vol. 125, no. 4, pp. 1032–1041, 2003. View at Publisher · View at Google Scholar · View at Scopus
  26. E. Sánchez, B. Z. Alizadeh, G. Valdigem et al., “MYO9B gene polymorphisms are associated with autoimmune diseases in Spanish population,” Human Immunology, vol. 68, no. 7, pp. 610–615, 2007. View at Publisher · View at Google Scholar · View at Scopus
  27. A. J. Monsuur, P. I. W. D. Bakker, B. Z. Alizadeh et al., “Myosin IXB variant increases the risk of celiac disease and points toward a primary intestinal barrier defect,” Nature Genetics, vol. 37, no. 12, pp. 1341–1344, 2005. View at Publisher · View at Google Scholar · View at Scopus
  28. L. L. E. Koskinen, I. R. Korponay-Szabo, K. Viiri et al., “Myosin IXB gene region and gluten intolerance: linkage to coeliac disease and a putative dermatitis herpetiformis association,” Journal of Medical Genetics, vol. 45, no. 4, pp. 222–227, 2008. View at Publisher · View at Google Scholar · View at Scopus
  29. J. Leonard, G. Haffenden, and W. Tucker, “Gluten challenge in dermatitis herpetiformis,” New England Journal of Medicine, vol. 308, no. 14, pp. 816–819, 1983. View at Google Scholar · View at Scopus
  30. B. Lioger, M. C. Machet, and L. Machet, “Dermatitis herpetiformis,” Presse Medicale, vol. 39, no. 10, pp. 1042–1048, 2010. View at Publisher · View at Google Scholar · View at Scopus
  31. A. Fasano, “Surprise from celiac disease,” Scientific American, vol. 301, no. 2, pp. 54–61, 2009. View at Publisher · View at Google Scholar · View at Scopus
  32. T. Matthias, S. Pfeiffer, C. Selmi, and M. E. Gershwin, “Diagnostic challenges in celiac disease and the role of the tissue transglutaminase-neo-epitope,” Clinical Reviews in Allergy and Immunology, vol. 38, no. 2-3, pp. 298–301, 2010. View at Publisher · View at Google Scholar · View at Scopus
  33. D. Schuppan, “Current concepts of celiac disease pathogenesis,” Gastroenterology, vol. 119, no. 1, pp. 234–242, 2000. View at Google Scholar · View at Scopus
  34. L. Shan, O. Molberg, I. Parrot et al., “Structural basis for gluten intolerance in Celiac Sprue,” Science, vol. 297, no. 5590, pp. 2275–2279, 2002. View at Publisher · View at Google Scholar · View at Scopus
  35. H. Skovbjerg, O. Noren, D. Anthonsen, J. Moller, and H. Sjöström, “Gliadin is a good substrate of several transglutaminases: possible implication in the pathogenesis of coeliac disease,” Scandinavian Journal of Gastroenterology, vol. 37, no. 7, pp. 812–817, 2002. View at Google Scholar
  36. H. Skovbjerg, C. Koch, D. Anthonsen, and H. Sjöström, “Deamidation and cross-linking of gliadin peptides by transglutaminases and the relation to celiac disease,” Biochimica et Biophysica Acta, vol. 1690, no. 3, pp. 220–230, 2004. View at Publisher · View at Google Scholar · View at Scopus
  37. B. Fleckenstein, Ø. Molberg, S. W. Qiao et al., “Gliadin T cell epitope selection by tissue transglutaminase in celiac disease. Role of enzyme specificity and pH influence on the transamidation versus deamidation reactions,” Journal of Biological Chemistry, vol. 277, no. 37, pp. 34109–34116, 2002. View at Publisher · View at Google Scholar · View at Scopus
  38. B. Fleckenstein, S. W. Qiao, M. R. Larsen, G. Jung, P. Roepstorff, and L. M. Sollid, “Molecular characterization of covalent complexes between tissue transglutaminase and gliadin peptides,” Journal of Biological Chemistry, vol. 279, no. 17, pp. 17607–17616, 2004. View at Publisher · View at Google Scholar · View at Scopus
  39. R. Ciccocioppo, A. Di Sabatino, C. Ara et al., “Gliadin and tissue transglutaminase complexes in normal and coeliac duodenal mucosa,” Clinical and Experimental Immunology, vol. 134, no. 3, pp. 516–524, 2003. View at Publisher · View at Google Scholar · View at Scopus
  40. V. Nehra, “New clinical issues in celiac disease,” Gastroenterology Clinics of North America, vol. 27, no. 2, pp. 453–465, 1998. View at Publisher · View at Google Scholar · View at Scopus
  41. G. Mantzaris and D. P. Jewell, “In vivo toxicity of a synthetic dodecapeptide from A gliadin in patients with coeliac disease,” Scandinavian Journal of Gastroenterology, vol. 26, no. 4, pp. 392–398, 1991. View at Google Scholar
  42. G. De Ritis, S. Auricchio, H. W. Jones, E. J. L. Lew, J. E. Bernardin, and D. D. Kasarda, “In vitro (organ culture) studies of the toxicity of specific A-gliadin peptides in celiac disease,” Gastroenterology, vol. 94, no. 1, pp. 41–49, 1988. View at Google Scholar · View at Scopus
  43. W. Dieterich, B. Esslinger, D. Trapp et al., “Cross linking to tissue transglutaminase and collagen favours gliadin toxicity in coeliac disease,” Gut, vol. 55, no. 4, pp. 478–484, 2006. View at Publisher · View at Google Scholar · View at Scopus
  44. I. Turchin and B. Barankin, “Dermatitis herpetiformis and gluten-free diet,” Dermatology Online Journal, vol. 11, no. 1, p. 6, 2005. View at Google Scholar · View at Scopus
  45. J. L. Garioch, H. M. Lewis, I. Sargent, J. N. Leonard, and L. Fry, “25 years' experience of a gluten-free diet in the treatment of dermatitis herpetiformis,” British Journal of Dermatology, vol. 131, no. 4, pp. 541–545, 1994. View at Google Scholar · View at Scopus
  46. P. Fabbri, Immunità e Cute. Le Dermatosi a Patogenesi Immunologica, Milano, Italy, Lingomed edition, 2012, http://www.lingomed.it.
  47. M. Calabuig, R. Torregosa, P. Polo et al., “Serological markers and celiac disease: a new diagnostic approach?” Journal of Pediatric Gastroenterology and Nutrition, vol. 10, no. 4, pp. 435–442, 1990. View at Google Scholar · View at Scopus
  48. W. Dieterich, T. Ehnis, M. Bauer et al., “Identification of tissue transglutaminase as the autoantigen of celiac disease,” Nature Medicine, vol. 3, no. 7, pp. 797–801, 1997. View at Publisher · View at Google Scholar · View at Scopus
  49. I. Caputo, M. V. Barone, S. Martucciello, M. Lepretti, and C. Esposito, “Tissue transglutaminase in celiac disease: role of autoantibodies,” Amino Acids, vol. 36, no. 4, pp. 693–699, 2009. View at Publisher · View at Google Scholar · View at Scopus
  50. S. Kárpáti, “Dermatitis herpetiformis: close to unravelling a disease,” Journal of Dermatological Science, vol. 34, no. 2, pp. 83–90, 2004. View at Publisher · View at Google Scholar · View at Scopus
  51. S. P. James, “Prototypic disorders of gastrointestinal mucosal immune function: celiac disease and Crohn's disease,” Journal of Allergy and Clinical Immunology, vol. 115, no. 1, pp. 25–30, 2005. View at Publisher · View at Google Scholar · View at Scopus
  52. V. Kumar, M. Jarzabek-Chorzelska, J. Sulej, M. Rajadhyaksha, and S. Jablonska, “Tissue transglutaminase and endomysial antibodies-diagnostic markers of gluten-sensitive enteropathy in dermatitis herpetiformis,” Clinical Immunology, vol. 98, no. 3, pp. 378–382, 2001. View at Publisher · View at Google Scholar · View at Scopus
  53. C. Rose, F. P. Armbruster, J. Ruppert, B. W. Igl, D. Zillikens, and I. Shimanovich, “Autoantibodies against epidermal transglutaminase are a sensitive diagnostic marker in patients with dermatitis herpetiformis on a normal or gluten-free diet,” Journal of the American Academy of Dermatology, vol. 61, no. 1, pp. 39–43, 2009. View at Publisher · View at Google Scholar · View at Scopus
  54. M. Caproni, C. Cardinali, D. Renzi, A. Calabró, and P. Fabbri, “Tissue transglutaminase antibody assessment in dermatitis herpetiformis [9],” British Journal of Dermatology, vol. 144, no. 1, pp. 196–197, 2001. View at Google Scholar · View at Scopus
  55. A. Tursi, G. Brandimarte, and G. M. Giorgetti, “Prevalence of antitissue transglutaminase antibodies in different degrees of intestinal damage in celiac disease,” Journal of Clinical Gastroenterology, vol. 36, no. 3, pp. 219–221, 2003. View at Publisher · View at Google Scholar · View at Scopus
  56. M. Sardy, S. Karpati, B. Merkl et al., “Epidermal transglutaminase (Tgase 3) is the autoanitgen of dermatitis herpetiformis,” Journal of Experimental Medicine, vol. 195, no. 6, pp. 747–757, 2002. View at Publisher · View at Google Scholar
  57. L. Lorand and R. M. Graham, “Transglutaminases: crosslinking enzymes with pleiotropic functions,” Nature Reviews Molecular Cell Biology, vol. 4, no. 2, pp. 140–156, 2003. View at Publisher · View at Google Scholar · View at Scopus
  58. K. Hitomi, “Transglutaminases in skin epidermis,” European Journal of Dermatology, vol. 15, no. 5, pp. 313–319, 2005. View at Google Scholar · View at Scopus
  59. M. R. Donaldson, J. J. Zone, L. A. Schmidt et al., “Epidermal transgluaminase deposits in perilesional and uninvolved skin in patients with dermatitis herpetiformis,” Journal of Investigative Dermatology, vol. 127, no. 5, pp. 1268–1271, 2007. View at Google Scholar
  60. E. V. Marietta, M. J. Camilleri, L. A. Castro, P. K. Krause, M. R. Pittelkow, and J. A. Murray, “Transglutaminase autoantibodies in dermatitis herpetiformis and celiac sprue,” Journal of Investigative Dermatology, vol. 128, no. 2, pp. 332–335, 2008. View at Publisher · View at Google Scholar · View at Scopus
  61. P. M. Heil, B. Volc-Platzer, F. Karlhofer et al., “Transglutaminases as diagnostically relevant autoantigens in patients with gluten sensitivity,” Journal of the German Society of Dermatology, vol. 3, no. 12, pp. 974–978, 2005. View at Publisher · View at Google Scholar · View at Scopus
  62. C. M. Hull, M. Liddle, N. Hansen et al., “Elevation of IgA anti-epidermal transglutaminase antibodies in dermatitis herpetiformis,” British Journal of Dermatology, vol. 159, no. 1, pp. 120–124, 2008. View at Publisher · View at Google Scholar · View at Scopus
  63. J. J. Zone, L. A. Schmidt, T. B. Taylor et al., “Dermatitis herpetiformis sera or goat anti-transglutaminase-3 transferred to human skin-grafted mice mimics dermatitis herpetiformis immunopathology,” Journal of Immunology, vol. 186, no. 7, pp. 4474–4480, 2011. View at Publisher · View at Google Scholar · View at Scopus
  64. E. Antiga, M. Caproni, and P. Fabbri, “Comment on “dermatitis herpetiformis sera or goat anti- transglutaminase-3 transferred to human skin-grafted mice mimics dermatitis herpetiformis immunopathology”,” Journal of Immunology, vol. 187, no. 2, pp. 595–596, 2011. View at Publisher · View at Google Scholar
  65. A. R. G. Cardones and R. P. Hall III, “Pathophysiology of dermatitis herpetiformis: a model for cutaneous manifestations of gastrointestinal inflammation,” Dermatologic Clinics, vol. 29, no. 3, pp. 469–477, 2011. View at Publisher · View at Google Scholar · View at Scopus
  66. M. Sárdy, S. Kárpáti, B. Merkl, M. Paulsson, and N. Smyth, “Epidermal transglutaminase (TGase 3) is the autoantigen of dermatitis herpetiformis,” Journal of Experimental Medicine, vol. 195, no. 6, pp. 747–757, 2002. View at Publisher · View at Google Scholar · View at Scopus
  67. K. Preisz, M. Sárdy, A. Horváth, and S. Kárpáti, “Immunoglobulin, complement and epidermal transglutaminase deposition in the cutaneous vessels in dermatitis herpetiformis,” Journal of the European Academy of Dermatology and Venereology, vol. 19, no. 1, pp. 74–79, 2005. View at Publisher · View at Google Scholar · View at Scopus
  68. R. P. Hall III, “Dermatitis herpetiformis,” Journal of Investigative Dermatology, vol. 99, no. 6, pp. 873–881, 1992. View at Google Scholar · View at Scopus
  69. S. J. P. Warren and C. J. Cockerell, “Characterization of a subgroup of patients with dermatitis herpetiformis with nonclassical histologic features,” American Journal of Dermatopathology, vol. 24, no. 4, pp. 305–308, 2002. View at Publisher · View at Google Scholar · View at Scopus
  70. J. B. Smith, T. B. Taylor, and J. J. Zone, “The site of blister formation in dermatitis herpetiformis is within the lamina lucida,” Journal of the American Academy of Dermatology, vol. 27, no. 2 I, pp. 209–213, 1992. View at Google Scholar · View at Scopus
  71. A. R. G. Cardones and R. P. Hall III, “Pathophysiology of dermatitis herpetiformis: a model for cutaneous manifestations of gastrointestinal inflammation,” Dermatologic Clinics, vol. 29, no. 3, pp. 469–477, 2011. View at Publisher · View at Google Scholar · View at Scopus
  72. A. D. Smith, R. D. Streilein, and R. P. Hall III, “Neutrophil CD11b, L-selectin and Fc IgA receptors in patients with dermatitis herpetiformis,” British Journal of Dermatology, vol. 147, no. 6, pp. 1109–1117, 2002. View at Publisher · View at Google Scholar · View at Scopus
  73. N. Mukaida, A. Harada, and K. Matsushima, “Interleukin-8 (IL-8) and monocyte chemotactic and activating factor (MCAF/MCP-1), chemokines essentially involved in inflammatory and immune reactions,” Cytokine and Growth Factor Reviews, vol. 9, no. 1, pp. 9–23, 1998. View at Publisher · View at Google Scholar · View at Scopus
  74. R. P. Hall III, F. Takeuchi, K. M. Benbenisty, and R. D. Streilein, “Cutaneous endothelial cell activation in normal skin of patients with dermatitis herpetiformis associated with increased serum levels of IL-8, sE-selectin, and TNF-α,” Journal of Investigative Dermatology, vol. 126, no. 6, pp. 1331–1337, 2006. View at Publisher · View at Google Scholar · View at Scopus
  75. R. P. Hall III, K. M. Benbenisty, C. Mickle, F. Takeuchi, and R. D. Streilein, “Serum IL-8 in patients with dermatitis herpetiformis is produced in response to dietary gluten,” Journal of Investigative Dermatology, vol. 127, no. 9, pp. 2158–2165, 2007. View at Publisher · View at Google Scholar · View at Scopus
  76. D. E. Loft, M. N. Marsh, G. I. Sandle et al., “Studies of intestinal lymphoid tissue. XII. Epithelial lymphocyte and mucosal responses to rectal gluten challenge in celiac sprue,” Gastroenterology, vol. 97, no. 1, pp. 29–37, 1989. View at Google Scholar · View at Scopus
  77. G. Kristjansson, J. Serra, L. Lööf, P. Venge, and R. Hällgren, “Kinetics of mucosal granulocyte activation after gluten challenge in coeliac disease,” Scandinavian Journal of Gastroenterology, vol. 40, no. 6, pp. 662–669, 2005. View at Publisher · View at Google Scholar · View at Scopus
  78. I. Strickland, L. E. Rhodes, B. F. Flanagan, and P. S. Friedmann, “TNF-α and IL-8 are upregulated in the epidermis of normal human skin after UVB exposure: correlation with neutrophil accumulation and E-selectin expression,” Journal of Investigative Dermatology, vol. 108, no. 5, pp. 763–768, 1997. View at Google Scholar · View at Scopus
  79. F. Takeuchi, R. D. Streilein, and R. P. Hall III, “Increased E-selectin, IL-8 and IL-10 gene expression in human skin after minimal trauma,” Experimental Dermatology, vol. 12, no. 6, pp. 777–783, 2003. View at Publisher · View at Google Scholar · View at Scopus
  80. J. Alonso-llamazares, L. E. Gibson, and R. S. Rogers, “Clinical, pathologic, and immunopathologic features of dermatitis herpetiformis: review of the Mayo Clinic experience,” International Journal of Dermatology, vol. 46, no. 9, pp. 910–919, 2007. View at Publisher · View at Google Scholar · View at Scopus
  81. M. Caproni, D. Torchia, E. Antiga et al., “The role of apoptosis in the pathogenesis of dermatitis herpetiformis,” International Journal of Immunopathology and Pharmacology, vol. 18, no. 4, pp. 691–699, 2005. View at Google Scholar · View at Scopus
  82. M. Caproni, C. Feliciani, A. Fuligni et al., “Th2-like cytokine activity in dermatitis herpetiformis,” British Journal of Dermatology, vol. 138, no. 2, pp. 242–247, 1998. View at Publisher · View at Google Scholar · View at Scopus